Concepedia

Samaneh Kabul

SK

4

Publications

105

Citations

4

H-Index

2015

Active since

Affiliations

Eli Lilly (United States)(Current)

Samaneh Kabul is an author at Eli Lilly (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

2015–2016

4

Publications

4

Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US

Magaly Perez‐Nieves, Samaneh Kabul, Urvi Desai et al. · Current Medical Research and Opinion · 2015 · 46 citations · Full text

Liraglutide Versus Exenatide Once Weekly: Persistence, Adherence, and Early Discontinuation

Maria Yu, Jin Xie, Laura Fernández Landó et al. · Clinical Therapeutics · 2015 · 28 citations

, , +1

Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial

Samaneh Kabul, Robert C. Hood, Ran Duan et al. · Health and Quality of Life Outcomes · 2016 · 20 citations · Full text

Real‐World Dosing Patterns of Atomoxetine in Adults with Attention‐Deficit/Hyperactivity Disorder

Samaneh Kabul, Carlos Alatorre, Leslie Montejano et al. · CNS Neuroscience & Therapeutics · 2015 · 11 citations · Full text

Rows per page

1–4 of 4